Wednesday, April 21, 2021
Home Latest Pharma-News

Latest Pharma-News

EU approves second indication of Sarclisa® for relapsed multiple myeloma

April 19 2021: "The European Commission approved Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with...

AstraZeneca receives US clearance of proposed acquisition of Alexion

April 16, 2021: "AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade...

Update of the WHO guidance on the treatment of drug susceptible tuberculosis

April 16, 2021: The WHO is convening a Guideline Development Group (GDG) to advise on updates needed to its recommendations on the...

FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab

April 16, 2021: "The U.S. FDA revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone,...

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer

April 16, 2021:The U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment...

Alchemab raises £60M A financing to advance novel platform

Apr 15, 2021: "Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally...

Amylyx Pharmaceuticals provides global regulatory update on amx0035 for ALS

April 14, 2021: Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s Disease and...

Novartis signs initial agreement with Roche to reserve capacity and implement the technology transfer for the production of Roche’s Actemra/RoActemra®

April 15, 2021: Novartis has signed an initial agreement with Roche to reserve capacity and implement the technology transfer for the production...

FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19

April 14, 2021: "During this worldwide public health emergency, the FDA has used a variety of tools to oversee facilities that manufacture...

U.S. FDA Approves Trodelvy® for Treatment of Metastatic Urothelial Cancer

April 13, 2021: Gilead Sciences, Inc. announced that the U.S. FDA has granted accelerated approval of Trodelvy® (sacituzumab govitecan-hziy) for use in adult...

Myovant, Pfizer strats dosing in Relugolix Contraceptive study

April 12, 2021: "Myovant Sciences and Pfizer Inc. announced that the first participant has been dosed in the Phase 3 SERENE study...

AZ’s Tagrisso approved in China in early lung cancer

April 14, 2021: "AstraZeneca’s Tagrisso (osimertinib) has been approved in China for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal...

Most Read

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.